Kevin Haigis Lab

Drumroll please...🥁 Our February 2025 meetings are now LIVE on our website! We're super excited to be heading to a BRAND NEW location, the Dominican Republic! 🇩🇴 We have some amazing conferences scheduled, head to our conference website for more info➡️fusion-conferences.com/conferences

Congrats Kevin Haigis, PhD, @DanaFarber's Chief Scientific Officer - recognized as a Fellow of the American Association for the Advancement of Science (@aaas) for distinguished contributions within biological sciences. @KevinHaigisLab Press release: ms.spr.ly/6019Y6Whf

Hard launch! First week as a #NewPI @DanaFarber 👩‍🔬 Interested in molecular imaging, chemistry or radiobiology? Postdoc and research tech positions to follow soon! Eternally grateful to @KevinHaigisLab and the lab for their support over the last 3.5 years 🧬🧫🧪☢️⭐️🔬

In @CEBP_AACR Effects of KRAS genetic interactions on outcomes in #LungCancer, #PancreaticCancer & #ColorectalCancer aacrjournals.org/cebp/article-a… Mining the massive @AACR GENIE database, this study identifies the prognostic impact of KRAS mutations on survival (across all three cancers, harboring a KRAS mutation has a deleterious impact on survival versus wild type alleles), although there are clear specific effects of individual variants. @KevinHaigisLab @KenLauLab @skopetz

A new leader of @NIH! Congratulations Dr. Bertagnolli!

From the newest issue— Allosteric Regulation of Switch-II Domain Controls #KRAS Oncogenicity, by @simanshu, @FredNatLab, @KevinHaigisLab et al. bit.ly/3SbUOuB @DanaFarberNews

NEW! On the RAS Dialogue Blog, Drs. Olesja Popow and Kevin Haigis share their insights into the persistent question of why #KRAS mutations drive cancers in some tissues and not in others. spr.ly/6010PUzzG

A special thank you to Clint Stalnecker and Channing Der @derlabunc for writing an excellent preview for our Molecular Cell paper out this week. cell.com/molecular-cell…

Next up, our very own conference chair @KevinHaigisLab takes the stage with a talk on TISSUE-SPECIFIC ONCOGENICITY OF K-RAS #AMC23

⁦@KevinHaigisLab⁩ opening remarks for the first Fusion conference ⁦@Fusion_Conf⁩ on animal models of cancer #AMC23

What a group! Some fantastic research shared so far, and even more to come, including our Poster Session, Gala Dinner and a Wine Tour at a local vineyard🐭🍷 #AMC23

Congratulations to the newly minted Dr. Bing Shui on his paper describing the global regulation of miRNA function by oncogenic K-Ras. Another piece of the puzzle. cell.com/molecular-cell…

Check out the Cancer Discovery papers highlighted in the new @AACR Journals collection, Targeting KRAS. bit.ly/435Ncvm @norbertkraut1 @KevinHaigisLab @AnnaFaragoMD

What's to blame for certain cancer outcomes? A pair of studies shows the Y chromosome plays a key role in colon and bladder cancers. @DanaFarber's Chief Scientific Officer Kevin Haigis (@KevinHaigisLab) talks with @USATODAY about the findings: usatoday.com/story/news/hea…

Don't forget to register before Friday! #AMC23 is shaping up to be a fantastic meeting, with an incredible line up of speakers & opportunities for poster presentation across the programme. 📌Poster submission: 19 May 2023 📆Registration: 19 May 2023 🌐fusion-conferences.com/conference/147

We are recruiting a research tech with some experience in handling a mouse colony. Location: MSKCC, Manhattan. Competitive pay and benefits. Email: venturaa@mskcc.org if interested. Please RT

Register today for @DanaFarber’s CSO Forum on 3/28 to learn how scientific collaborations with researchers and physicians worldwide help advance revolutionary science and extraordinary care for patients with cancer. Sign-up today for this virtual event: dfci.zoom.us/webinar/regist…

🌟At #AACRras23: @KevinHaigisLab speaks about K-RAS hyperexchange mutants in colorectal cancer. See his Review article published in @CD_AACR last year: Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention 👇 aacrjournals.org/cancerdiscover…

🌟🌟🌟@KevinHaigisLab speaks today at #AACRras23. Find his review about Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention published last year in @CD_AACR for the 40 years anniversary 👇 aacrjournals.org/cancerdiscover…

Deadline Extended! There's just one more week to secure discounted registration & submit an abstract for talk consideration at #AMC23. With an incredible speaker line up, this is not one to miss! 📆Talk submission: 03 Mar 2023 🌐fusion-conferences.com/conference/147 @KevinHaigisLab @SageJulien